Skip to content

Prophylactic Moxibustion in preventing post-operative urinary retention of hemorrhoidectomy: a protocol for a randomized controlled trial

Prophylactic Moxibustion in preventing post-operative urinary retention of hemorrhoidectomy: a protocol for a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039350
Enrollment
Unknown
Registered
2020-10-24
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary retention after hemorrhoidectomy

Interventions

Control group: Tamsulosin Hydrochloride

Sponsors

Changshu Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Those who met the diagnostic criteria for mixed hemorrhoids (grade III or grade IV mixed hemorrhoids); (2) The age of the patients ranged from 18 to 70 years old; (3) There was no obvious deformity of anus before operation; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who have undergone mixed hemorrhoids surgery, or have other surgical procedures, or have other anorectal diseases; (2) Patients with other anorectal diseases; (3) Women in pregnancy, lactation and menstruation; (4) Combined with serious primary diseases such as heart, cerebrovascular, liver and kidney, malignant tumor, etc.; (5) Combined with benign prostatic hyperplasia, neurogenic bladder, urethral injury, urethral stricture and other urinary diseases; (6) Patients with abdominal ulcer, injury, infection, scar constitution and allergic constitution.

Design outcomes

Primary

MeasureTime frame
Incidence of pour;

Secondary

MeasureTime frame
Catheterization rate;Incidence of urinary tract infection;Average length of stay;

Countries

China

Contacts

Public ContactJi Lijiang

Changshu Traditional Chinese Medicine Hospital

ji512@163.com+86 13962340746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026